T Rowe Price Group
TROW · NASDAQ
About TROW
- Employees
- 7,507
- Headquarters
- Baltimore, Maryland
- Listed
- Jan 4, 1986
- Sector
- Financials
- Industry
- Capital Markets
- Website
- troweprice.com
TROW key statistics
- Market cap
- 21.35B
- Price-earnings ratio
- 10.04
- Dividend yield
- 5.31%
- Average volume
- 1.87M
- Volume
- 1.90M
- Open price
- $100.10
- High today
- $102.50
- Low today
- $99.84
- 52 Week high
- $122.00
- 52 Week low
- $85.22
T Rowe Price Group (TROW) at a glance
As of Oct 20, 2026, T Rowe Price Group (TROW) shares are priced at $102.13, giving the company a market cap of 21.35B, a price-to-earnings ratio of 10.04 and a dividend yield of 5.31%.
Today the stock has traded between $99.84 and $102.50. The current price is 2.3% above the day's low and 0.4% below its high.
Volume so far is 1.90M shares, in line with the average of 1.87M shares a day.
Over the past year T Rowe Price Group has ranged from $85.22 to $122.00, and now sits 46% of the way up that range.
T Rowe Price Group met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported $2.57 per share against an estimate of $2.55.
The average analyst price target is $109.45, 7.2% above the current price, from 11 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy0.0%
- Hold63.6%
- Sell36.4%
- Low
- $90.90
- Now
- $102.13
- High
- $130.20
TROW earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 6 of the last 8 quarters, by 4.8% on average.
- Q3 FY24: reported $2.57 per share against an estimate of $2.38
- Q4 FY24: reported $2.12 per share against an estimate of $2.24
- Q1 FY25: reported $2.23 per share against an estimate of $2.17
- Q2 FY25: reported $2.24 per share against an estimate of $2.18
- Q3 FY25: reported $2.81 per share against an estimate of $2.56
- Q4 FY25: reported $2.44 per share against an estimate of $2.52
- Q1 FY26: reported $2.52 per share against an estimate of $2.40
- Q2 FY26: reported $2.57 per share against an estimate of $2.55
TROW news
- Press releasePRNewswire
- Press releasePRNewswire
T. ROWE PRICE GROUP REPORTS MONTH-END ASSETS UNDER MANAGEMENT FOR SEPTEMBER 2026
- Press releasePRNewswire
T. ROWE PRICE LAUNCHES DYNAMIC EMERGING MARKETS BOND EXCHANGE TRADED FUND
- Press releasePRNewswire
T. ROWE PRICE EXPLORES WHAT INVESTORS CAN LEARN FROM SHELL CEO'S VIEW OF AN "ENERGY ADDITION" ERA
- Press releasePRNewswire
T. ROWE PRICE DEBUTS BIOTECH, SMALL-CAP, AND MID-CAP EXCHANGE TRADED FUNDS
- Press releasePRNewswire
T. ROWE PRICE STUDY FINDS DC CONSULTANTS AND ADVISORS ARE MOVING FROM AI EXPLORATION TO EXECUTION, WHILE PRIVATE ASSETS AND PERSONALIZATION GAIN MOMENTUM
- Press releasePRNewswire
T. ROWE PRICE GROUP REPORTS MONTH-END ASSETS UNDER MANAGEMENT FOR AUGUST 2026
- Press releasePRNewswire
T. ROWE PRICE WORKS WITH ANTHROPIC TO BRING CLAUDE TO MORE OF ITS INVESTMENT PROCESS
Similar companies
Companies in the same industry as T Rowe Price Group
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
- MDEXMadison Technologies$0.0005−37.50%
- SDSTStardust Power$0.02−23.66%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.